Innovations in Airway Diseases

Dear Colleagues,

Background and history of this topic: This Special Issue on "Innovations in Airway Diseases" aims to provide a comprehensive overview of the latest advances in research, diagnosis, and treatment of airway diseases. This field has witnessed significant progress over the past decades, influenced by technological advances and a deeper understanding of the biological underpinnings of airway pathophysiology. By bringing together leading experts and researchers, this issue seeks to highlight the innovative approaches that are sha** the future of respiratory medicine.

Historical Context and Evolution: The background and history of airway diseases are marked by pivotal discoveries that have transformed patient outcomes. From the development of bronchodilators to the advent of personalized medicine based on genetic profiles, the journey of airway disease management reflects a broader narrative of medical advancement. This section of the issue will trace these developments, setting the stage for a discussion on how historical insights are being integrated into modern therapeutic strategies.

Aim and Scope of the Issue: The primary aim of this Special Issue is to encapsulate the cutting-edge research that represents the frontier of knowledge in the field of airway diseases. It is particularly focused on novel diagnostic techniques, therapeutic interventions, and prognostic assessment tools that have emerged in recent years. The scope of this issue extends to molecular biology, clinical trials, and patient-centered care approaches, aiming to cover a broad spectrum of topics that promise to redefine standards and improve clinical outcomes.

Showcasing Cutting-edge Research: By highlighting recent innovations, this section of the Special Issue will focus on groundbreaking research that offers new insights into the mechanisms of airway diseases. It will feature studies on immune modulation, the impact of environmental factors on airway health, and advancements in biotechnology that facilitate more precise interventions. Contributions will include detailed analyses of clinical trial data, reviews of emerging therapies, and discussions on the potential of new research methodologies to address unresolved challenges in the field.

Call for Papers and Contribution: In pursuit of expanding the discourse within this field, this issue invites submissions from a diverse array of scholarly contributions. Desired articles include original research papers that introduce new findings, comprehensive review articles that provide in-depth insights into current knowledge, and case studies that explore innovative treatment applications. This call for papers emphasizes the importance of contributions that not only present scientific rigor but also propose practical implications for clinical practice, aiming to foster a richer understanding and enhanced therapeutic approaches in the treatment of airway diseases.

Dr. Ourania S. Kotsiou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• airway pathophysiology
• respiratory therapeutics
• novel diagnostic techniques
• personalized medicine
• clinical trials in airway diseases
• innovative treatment strategies
• molecular mechanisms
• biotechnological advances
• environmental impacts
• advanced diagnostic tools